# Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, Analgesia.
*Date:* December 1, 2003.
*Time:* 4 p.m. to 5 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
*Contact Person:* Daniel R. Kenshalo, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD 20892, 301-435-1255.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, Alkaline Phosphatase.
*Date:* December 2, 2003.
*Time:* 1 p.m. to 2 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
*Contact Person:* Sherry L. Dupere, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5136, MSC 7843, Bethesda, MD 20892, 301-435-1021, *[email protected]* .
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, Pain.
*Date:* December 2, 2003.
*Time:* 12 p.m. to 2 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
*Contact Person:* Daniel R. Kenshalo, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD 20892, 301-435-1255.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, ZRG1 SSS-C (03) Reviews in Child Psychopathology.
*Date:* December 4, 2003.
*Time:* 1 p.m. to 2 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
*Contact Person:* Mary Sue Krause, MED; Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3182, MSC 7848, Bethesda, MD 20892, 301-435-0902, *[email protected].*
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, ZRG1 SSS-5 03 M: Dermatalogy/Rheumatology.
*Date:* December 10, 2003.
*Time:* 1 p.m. to 3 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
*Contact Person:* Jeffrey E. DeClue, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4114, MSC 7814, MSC 7814, Bethesda, MD 20892, 301-594-6376.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, NeuroAIDS Member Conflicts.
*Date:* December 12, 2003.
*Time:* 11 a.m. to 1:30 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
*Contact Person:* Eduardo A. Montalvo, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5212, MSC 7852, Bethesda, MD 20892, 301-435-1168, *[email protected].*
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, Replicative Cellular Senescence.
*Date:* December 12, 2003.
*Time:* 3 p.m. to 5 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
*Contact Person:* Sherry L. Dupere, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5136, MSC 7843, Bethesda, MD 20892, 301-435-1021, *[email protected].*
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, At Risk Youth.
*Date:* December 15, 2003.
*Time:* 1 p.m. to 2:30 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
*Contact Person:* Deborah L. Young-Human, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4188, MSC 7808, Bethesda, MD 20892, (301) 451-8008, *[email protected].*
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, Receptor Structure and Function.
*Date:* December 15, 2003.
*Time:* 1 p.m. to 3 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
*Contact Person:* Joanne T. Fujii, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5204, MSC 7850, Bethesda, MD 20892, (301) 435-1178, *[email protected].*
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, Galectin Biology.
*Date:* December 17, 2003.
*Time:* 3 p.m. to 4 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
*Contact Person:* Sherry L. Dupere, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5136, MSC 7843, Bethesda, MD 20892, (301) 435-1021, *[email protected].*
*Name of Committee:* Center for Scientific Review Special Emphasis Panel, ZRG1 NNB (03) Methylphendate and Development.
*Date:* December 19, 2003.
*Time:* 11 a.m. to 1 p.m.
*Agenda:* To review and evaluate grant applications.
*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
*Contact Person:* Richard Marcus, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5168, MSC 7844, Bethesda, MD 20892, 301-435-1245, *[email protected].*
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93-837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)
Dated: November 25, 2003.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.